AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 35 filers reported holding AQUINOX PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,000 | 0.0% | 1,221 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | 0.0% | 1,221 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -97.3% | 1,221 | -84.4% | 0.00% | – |
| Q1 2018 | $110,000 | +129.2% | 7,846 | +170.1% | 0.00% | – |
| Q1 2017 | $48,000 | -86.3% | 2,905 | -88.4% | 0.00% | – |
| Q4 2016 | $350,000 | +4.2% | 25,126 | 0.0% | 0.00% | – |
| Q3 2016 | $336,000 | +102.4% | 25,126 | 0.0% | 0.00% | – |
| Q2 2016 | $166,000 | -25.2% | 25,126 | 0.0% | 0.00% | – |
| Q1 2016 | $222,000 | -27.9% | 25,126 | +1.7% | 0.00% | – |
| Q4 2015 | $308,000 | -25.6% | 24,700 | -16.0% | 0.00% | -100.0% |
| Q3 2015 | $414,000 | +1433.3% | 29,405 | +653.0% | 0.00% | – |
| Q2 2015 | $27,000 | -15.6% | 3,905 | 0.0% | 0.00% | – |
| Q1 2015 | $32,000 | – | 3,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 246,877 | $3,143,000 | 0.72% |
| Broadfin Capital, LLC | 510,500 | $6,499,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 190,000 | $2,419,000 | 0.55% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 510,597 | $6,500,000 | 0.20% |
| Baker Brothers Advisors | 1,211,851 | $15,427,000 | 0.20% |
| Perceptive Advisors | 130,000 | $1,655,000 | 0.17% |
| HIGHLAND CAPITAL MANAGEMENT LP | 266,271 | $3,390,000 | 0.14% |
| Visium Asset Management, LP | 298,804 | $3,804,000 | 0.06% |
| Alyeska Investment Group, L.P. | 100,290 | $1,277,000 | 0.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 62,387 | $794,000 | 0.03% |